As of 2025-03-23, the Relative Valuation of Magenta Therapeutics Inc (MGTA) is (13.16) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Magenta Therapeutics Inc based on Relative Valuation is -1981.2%.
The range of the Relative Valuation is (6.45) - (19.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 16.3x | 10.6x |
| Forward P/E multiples | 5.1x - 15.2x | 10.1x |
| Fair Price | (6.45) - (19.24) | (13.16) |
| Upside | -1022.5% - -2849.4% | -1981.2% |
| Date | P/E |